The abstract is read at the publisher; the summary is JClub's.
Targeted peri-operative prophylaxis using novel agents (T-PAPnew) in adults with CRE colonization undergoing liver transplantation is linked to fewer CRE infections at 15 days (ATE −0.146, P=.002).
- Why it matters: CRE-colonized liver transplant recipients face high early post-operative infection risk, and standard prophylaxis may not adequately address the specific resistant strains they carry.
- What they did: In a multinational observational cohort of 408 CRE pre-transplant carriers, investigators compared T-PAP versus standard prophylaxis, defining T-PAP by in vitro activity against the colonizing strain and modeling effects with augmented inverse probability weighting.
- The result: CRE infections occurred in 21.4% at 15 days and 26.0% at 30 days; T-PAPnew showed a significant reduction at 15 days (ATE −0.146, P=.002) but not at 30 days (ATE −0.056, P=.320), while T-PAPold showed no significant effect.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.